Menu
  • About Us
    • History
    • Vision & Mission
    • Board Of Directors
  • Our Business
    • Formulations
      • Americas
      • European Union (EU)
      • ACASIA
    • Active Pharmaceutical Ingredients
    • Contract Manufacturing
  • Our Manufacturing Sites
    • Goa
    • Baddi
    • Ghaziabad
    • Roha
    • Pithampur
    • Kolhapur
  • R & D
    • Research Development
    • Priority Areas
    • Research Alliances & Partnerships
    • Philosophy & Focus
  • Responsibility
    • Values & Commitments
    • Environment, Health & Safety
    • Quality & Reliability
  • Investor Info
    • Financial Results
    • Annual General Meeting / Annual Report
    • Statutory Communications
    • Shareholding Pattern
    • Policies / ESOP Scheme
    • Memorandum of Association & Articles of Association
    • Shareholders Contact
    • Dividend
    • Investor Awareness - SEBI Investor Website/KYC/ SMART ODR and Demat
    • Saksham Niveshak / Special Window For Re Lodgement
    • BSE Stockwatch
    • Postal Ballot
    • Open Offer by Ipca Laboratories Limited
    • Buyback
  • Contact Us
  • Careers

Buyback

Home / Investors Info / Open Offer by Ipca Laboratories Limited

Open Offer by Ipca Laboratories Limited

Recommendation of Committee of Independent Directors (IDC) – Business Standard – August 21, 2023
Recommendation of Committee of Independent Directors (IDC) – Mumbai Lakshadeep – August 21, 2023
Letter of Offer – August 18, 2023
Public Announcement cum Corrigendum to Detailed Public Statement (DPS) – August 14, 2023
Detailed Public Statement – May 2, 2023
Public Announcement – April 24, 2023

  • About Us
  • Our Manufacturing Sites
  • R & D
  • Responsibility
  • Investors Info
  • Careers
  • Terms of Use
  • Contact Us
  • Sitemap
  • USA Flag Unichem USA
  • |
  • EU Flag Unichem Europe
  • |
  • ACASIA ACASIA
Copyright © Unichem Laboratories. All Rights Reserved. Follow us on Linked In Linked In
Scroll